Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Be-tabs Pharmaceuticals is a prominent South African pharmaceutical company focused on the development and manufacture of generic medicines. Established in 1974, the company has grown into one of the largest manufacturers of tablets and capsules in the region, operating from its headquarters in Johannesburg. The firm's extensive portfolio covers diverse therapeutic categories, including analgesics, anti-infectives, and nutritional supplements. In 2006, Be-tabs was acquired by Ranbaxy Laboratories, which was later integrated into Sun Pharmaceutical Industries, further strengthening its distribution and manufacturing capabilities. The company remains a vital supplier of affordable healthcare products to both the private and public sectors in Southern Africa. Its manufacturing facilities are GMP-compliant, ensuring high standards for its wide range of over-the-counter and prescription medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Be-tabs Pharmaceuticals.